Patents by Inventor Robert Mansbach

Robert Mansbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220110908
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Application
    Filed: August 23, 2021
    Publication date: April 14, 2022
    Applicant: Currax Pharmaceuticals LLC
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Publication number: 20210393567
    Abstract: Methods of improving the pharmacokinetics of doxepin in a patient.
    Type: Application
    Filed: September 6, 2021
    Publication date: December 23, 2021
    Applicant: Currax Pharmaceuticals LLC
    Inventors: Cara Baron Casseday, Elizabeth Ludington, Michael Skinner, Susan E. Dubé, Roberta L. Rogowski, Philip Jochelson, Robert Mansbach
  • Publication number: 20210283094
    Abstract: A composition comprising doxepin, or a pharmaceutically acceptable salt, or prodrug thereof, and a compound that enhances sleep onset, sleep maintenance or reduces early morning awakenings. These compositions are useful for treating multiple manifestations of insomnia.
    Type: Application
    Filed: May 24, 2021
    Publication date: September 16, 2021
    Applicants: Currax Pharmaceuticals LLC, ProCom One, Inc.
    Inventors: Philip Jochelson, Robert Mansbach, Michael Skinner, Neil B. Kavey
  • Patent number: 11110074
    Abstract: Methods of improving the pharmacokinetics of doxepin in a patient.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: September 7, 2021
    Assignee: Currax Pharmaceuticals LLC
    Inventors: Cara Baron Casseday, Elizabeth Ludington, Michael Skinner, Susan E. Dubé, Roberta L. Rogowski, Philip Jochelson, Robert Mansbach
  • Patent number: 11096920
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Grant
    Filed: February 3, 2020
    Date of Patent: August 24, 2021
    Assignee: Currax Pharmaceuticals LLC
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Patent number: 11013712
    Abstract: A composition comprising doxepin, or a pharmaceutically acceptable salt, or prodrug thereof, and a compound that enhances sleep onset, sleep maintenance or reduces early morning awakenings. These compositions are useful for treating multiple manifestations of insomnia.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: May 25, 2021
    Assignee: Currax Pharmaceuticals LLC
    Inventors: Philip Jochelson, Robert Mansbach, Michael Skinner, Neil B. Kavey
  • Publication number: 20200276151
    Abstract: Methods of improving the pharmacokinetics of doxepin in a patient.
    Type: Application
    Filed: May 18, 2020
    Publication date: September 3, 2020
    Inventors: Cara Baron Casseday, Elizabeth Ludington, Michael Skinner, Susan E. Dubé, Roberta L. Rogowski, Philip Jochelson, Robert Mansbach
  • Publication number: 20200170991
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Application
    Filed: February 3, 2020
    Publication date: June 4, 2020
    Applicant: Currax Pharmaceuticals LLC
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Patent number: 10653660
    Abstract: Methods of improving the pharmacokinetics of doxepin in a patient.
    Type: Grant
    Filed: February 17, 2017
    Date of Patent: May 19, 2020
    Assignee: Currax Pharmaceuticals LLC
    Inventors: Cara Baron Casseday, Elizabeth Ludington, Michael Skinner, Susan E. Dubé, Roberta L. Rogowski, Philip Jochelson, Robert Mansbach
  • Patent number: 10548871
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: February 4, 2020
    Assignee: Currax Pharmaceuticals LLC
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Publication number: 20200000763
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Application
    Filed: March 5, 2018
    Publication date: January 2, 2020
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Publication number: 20180256533
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Application
    Filed: March 5, 2018
    Publication date: September 13, 2018
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Patent number: 9907780
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Grant
    Filed: December 30, 2016
    Date of Patent: March 6, 2018
    Assignee: Pernix Sleep, Inc.
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Publication number: 20170172973
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Application
    Filed: December 30, 2016
    Publication date: June 22, 2017
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Publication number: 20170157140
    Abstract: Methods of improving the pharmacokinetics of doxepin in a patient.
    Type: Application
    Filed: February 17, 2017
    Publication date: June 8, 2017
    Inventors: Cara Baron Casseday, Elizabeth Ludington, Michael Skinner, Susan E. Dubé, Roberta L. Rogowski, Philip Jochelson, Robert Mansbach
  • Patent number: 9572814
    Abstract: Methods of improving the pharmacokinetics of doxepin in a patient.
    Type: Grant
    Filed: October 16, 2012
    Date of Patent: February 21, 2017
    Assignee: Pernix Sleep, Inc.
    Inventors: Cara Baron Casseday, Elizabeth Ludington, Michael Skinner, Susan E. Dubé, Roberta L. Rogowski, Philip Jochelson, Robert Mansbach
  • Patent number: 9532971
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: January 3, 2017
    Assignee: Pernix Sleep, Inc.
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Baron Casseday, Meredith Perry, Bryan Knox
  • Publication number: 20130259936
    Abstract: The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
    Type: Application
    Filed: May 20, 2013
    Publication date: October 3, 2013
    Inventors: Luigi Schioppi, Brian Talmadge Dorsey, Michael Skinner, John Carter, Robert Mansbach, Philip Jochelson, Roberta L. Rogowski, Cara Casseday, Meredith Perry, Bryan Knox
  • Publication number: 20130005655
    Abstract: A composition comprising doxepin, or a pharmaceutically acceptable salt, or prodrug thereof, and a compound that enhances sleep onset, sleep maintenance or reduces early morning awakenings. These compositions are useful for treating multiple manifestations of insomnia.
    Type: Application
    Filed: September 12, 2012
    Publication date: January 3, 2013
    Applicant: Somaxon Pharmaceuticals, Inc.
    Inventors: Philip Jochelson, Robert Mansbach, Michael Skinner, Neil B. Kavey
  • Publication number: 20110166215
    Abstract: Methods of improving the pharmacokinetics of doxepin in a patient.
    Type: Application
    Filed: January 14, 2011
    Publication date: July 7, 2011
    Applicant: SOMAXON PHARMACEUTICALS, INC.
    Inventors: Cara Baron CASSEDAY, Elizabeth LUDINGTON, Michael SKINNER, Susan DUBÉ, Roberta L. ROGOWSKI, Philip JOCHELSON, Robert MANSBACH